Viewing entries posted in 2013
University Medical Center Schleswig-Holstein reports that the alfapump system has been implanted for the first time in Schleswig-Holstein, at the centre’s facility in Kiel.
Daily Mail reports on a patient from Sunderland whose life has been improved by the alfapump® system
Professor David Talbot from Freeman Hospital, Newcastle, and his patient share their experiences with the alfapump system.
alfapump enjoyed extensive coverage and was featured on Sky News, BBC London television and radio, BBC 5 live and a host of regional radio programmes.
Keep a look out for the alfapump system in Wednesday's TV and radio broadcasts in the UK. Professor Rajiv Jalan, from UCL institute for Liver and Digestive Health, Royal Free Hospital, London and one of his patients are taking part in a series of interviews.
Sequana Medical was delighted to attend ‘Journées pluridisciplinaires de pathologie, hépatobiliare, pancréatique et digestives’, a gastro-enterology congress organised by the University Hospital of Geneva.
Sequana Medical appoints Vingmed/ViCare Medical as distributor of the alfapump® system in Scandinavia
Sequana Medical is pleased to announce the appointment of Vingmed and ViCare as distributor for the alfapump system in Norway, Sweden and Denmark.
Sequana Medical presents alfapump® at the 23rd Congress of Gastroenterology and Visceral Surgery in Dresden
Sequana Medical was delighted to sponsor this important event, which took place in Dresden on the 8th and 9th of November.
Sequana Medical was proud to present the alfapump system at this year’s Bavarian Annual Conference for Gastroenterology, held in Munich, Germany.
Leading Swiss Sunday newspaper ‘Sonntagszeitung’ reports on the growing problem of fatty liver disease and on Inselspital Bern’s adoption of the alfapump system for ascites.
Dr Christina Fotopoulou, Consultant Gynecological Oncologist at Imperial College NHS Trust, London, presented the abstract ‘Continuous low-flow ascites drainage and sequential non-invasive tumor-cell sampling through urinary bladder via the alfapump closed system in platinum-resistant-ovarian-cancer (PROC), at the 18th International Meeting of the European Society of Gynaecological Oncology (ESGO), held in Liverpool, UK this week.